CN Patent

CN106132415A — 具有增加的注射速度的阿立哌唑制剂

Assigned to Alkermes Inc · Expires 2016-11-16 · 10y expired

What this patent protects

本发明涉及包含式(I)化合物的药物组合物，其可用于使用快速注射速率肌内递送抗精神病药。

USPTO Abstract

本发明涉及包含式(I)化合物的药物组合物，其可用于使用快速注射速率肌内递送抗精神病药。

Drugs covered by this patent

Patent Metadata

Patent number
CN106132415A
Jurisdiction
CN
Classification
—
Expires
2016-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.